External Publication from BMJ Open: Narrative review of C reactive protein (CRP) point-of-care testing (POCT) and antibacterial use in patients presenting with respiratory tract infections symptoms
LumiraDx SARS-CoV-2 Antibody Test Demonstrates High Sensitivity and Specificity in Point of Care Testing for COVID-19
LumiraDx SARS-CoV-2 Antigen Test Demonstrates High Sensitivity in Point of Care Testing for COVID-19
NHS Scotland Assessment of LumiraDx SARS-CoV-2 Ab Test
Performance evaluation of a rapid point-of-care microfluidic immunofluorescence assay for the detection of SARS-CoV-2 antibodies
COVID-19 Asymptomatic Testing with POC LumiraDx SARS-CoV-2 Antigen Test
SARS-CoV-2 Ag Test Superior Analytical Sensitivity – Technical Bulletin
The quantitative LumiraDx D-Dimer Test provides lab-comparable results at the point of care
CTSB enables the next step of normal life to resume: Usage of LumiraDx SARS-CoV-2 Ag Pool Test supports opening strategies for social events in Germany
Performance of a SARS-CoV-2 Antigen Pool Test to aid diagnosis of acute COVID-19 at the point of care
Performance evaluation of the quantitative point-of-care LumiraDx D-Dimer Test
The LumiraDx SARS-CoV-2 Antigen Test demonstrated as more sensitive compared to SD Biosensor Standard Q COVID-19 Rapid Antigen Test in an independent evaluation on behalf of the Swiss Federal Office of Public Health
The LumiraDx SARS-CoV-2 Antigen Test aligns with detection of infectious samples from immunocompetent individuals with none to mild and moderate symptoms
Summary of the Evaluation of 32 rapid tests for detection of IgG antibodies against SARS-CoV-2 (NOKLUS)
Establishing an Anticoagulation “Drive Through” Clinic during the COVID-19 Pandemic using the LumiraDx Platform INR Test
An evaluation of the detection of SARS-CoV-2 antigen in a cohort of symptomatic and asymptomatic patients: Report from the evaluation of SKUP
Performance evaluation of the LumiraDx SARS-CoV-2 Antigen Test to aid diagnosis of acute COVID-19 at the point of care
Evaluation of the Accuracy of the LumiraDx INR Test Using Patients in Receipt of Phenprocoumon Anticoagulation Therapy
Evaluation of the Accuracy of INR values measured by a POCT system in a German Clinic with patients taking Phenprocoumon as VKA Therapy.
Laboratory accuracy assessment of a novel INR Point-of-Care Test compared with laboratory reference methods used across four independent clinical sites.
Evaluation of the Accuracy of INR values measured by LumiraDx in patients taking Phenprocoumon.
Sensitivity of LumiraDx INR Testing to Interference from Antiphospholipid Antibodies (aPL)
The LumiraDx Platform INR Test: Performance and ease of use in an anticoagulation clinic setting
LumiraDx INR Test: Laboratory Accuracy Assessment with the ACL Elite and Sysmex Reference Methods
Valutazione di LumiraDx Platform e del test INR presso lo studio medico dei Dott.ri Schreiber, Steinbauer e Dechant
Performance of the LumiraDx Platform INR Test in a point-of-care setting compared to an established laboratory reference method
Point of care testing in primary care in Europe: Improving pathways and patient outcomes
Point-of-care testing in the community pharmacy – improving access to care.